General MedicationsORALGeneric

SOLODYN

MINOCYCLINE HYDROCHLORIDE

Standard Dose

EQ 55MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview SOLODYN is listed in Drugs@FDA under application 050808 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MINOCYCLINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 55MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAUSCH Submission history Latest submission status date: 2025-04-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview SOLODYN is listed in Drugs@FDA under application 050808 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MINOCYCLINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 55MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAUSCH Submission history Latest submission status date: 2025-04-01 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.